Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

Completed · Not applicable

Conditions studied: Breast Cancers

In brief

The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.

Key facts

Study ID

NCT00721903

Run by

University of Michigan

People needed

88

Starts

2000-03-01

Expected to finish

2014-09-01

Last updated by the study team

2016-05-05

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Newly diagnosed breast cancer prior to receiving breast cancer therapy.
• Diagnosis of breast cancer must be confirmed by fine needle aspiration or core biopsy.

You may not qualify if…

• Poorly controlled diabetes.
• Contralateral mastectomy prior to neoadjuvant chemotherapy.
• Not a surgical candidate.
• No previous axillary lymph node dissection.

Where it is running

• University of Michigan Hospital — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.